Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.55% | 6.77% | |||
| Total Other Revenue | -716.67% | 500.00% | |||
| Total Revenue | 12.50% | 6.77% | |||
| Cost of Revenue | -1.61% | 16.38% | |||
| Gross Profit | 85.96% | -25.34% | |||
| SG&A Expenses | 15.88% | 8.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.55% | 14.03% | |||
| Operating Income | 52.59% | -98.58% | |||
| Income Before Tax | 49.84% | 68.69% | |||
| Income Tax Expenses | 1,720.78% | 5.84% | |||
| Earnings from Continuing Operations | 22.36% | 68.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.36% | 68.35% | |||
| EBIT | 52.59% | -98.58% | |||
| EBITDA | 56.87% | -113.02% | |||
| EPS Basic | 22.42% | 68.42% | |||
| Normalized Basic EPS | 47.39% | 68.77% | |||
| EPS Diluted | 17.86% | 67.69% | |||
| Normalized Diluted EPS | 47.39% | 68.77% | |||
| Average Basic Shares Outstanding | 0.05% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||